Opko Health Inc (OPK) - Total Assets
Based on the latest financial reports, Opko Health Inc (OPK) holds total assets worth $1.83 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see OPK cash generation efficiency for how efficiently the company converts equity into cash flow.
Opko Health Inc - Total Assets Trend (1995–2025)
This chart illustrates how Opko Health Inc's total assets have evolved over time, based on quarterly financial data. See today's stock price for Opko Health Inc for real-time trading data and today's change.
Opko Health Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Opko Health Inc's total assets of $1.83 Billion consist of 30.1% current assets and 69.9% non-current assets. Explore OPK net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.1% |
| Accounts Receivable | $126.12 Million | 6.5% |
| Inventory | $65.82 Million | 3.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $516.28 Million | 26.7% |
| Goodwill | $484.29 Million | 25.1% |
Asset Composition Trend (1995–2025)
This chart illustrates how Opko Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Opko Health Inc's current assets represent 30.1% of total assets in 2025, a decrease from 83.1% in 1995.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2025, down from 83.1% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 13.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 26.7% of total assets.
Opko Health Inc Competitors by Total Assets
Key competitors of Opko Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
BGI Genomics Co Ltd
SHE:300676
|
China | CN¥11.35 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716
|
China | CN¥1.59 Billion |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.66 Million |
|
Check-Cap Ltd
F:7CC
|
Germany | €7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
Opko Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.35 | 3.41 | 1.97 |
| Quick Ratio | 2.93 | 3.02 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $350.87 Million | $412.15 Million | $274.48 Million |
Opko Health Inc - Advanced Valuation Insights
This section examines the relationship between Opko Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.04 |
| Latest Market Cap to Assets Ratio | 0.61 |
| Asset Growth Rate (YoY) | -12.2% |
| Total Assets | $1.93 Billion |
| Market Capitalization | $1.19 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Opko Health Inc's assets below their book value (0.61x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Opko Health Inc's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Opko Health Inc (1995–2025)
The table below shows the annual total assets of Opko Health Inc from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.93 Billion | -12.19% |
| 2024-12-31 | $2.20 Billion | +9.37% |
| 2023-12-31 | $2.01 Billion | -7.18% |
| 2022-12-31 | $2.17 Billion | -9.69% |
| 2021-12-31 | $2.40 Billion | -2.97% |
| 2020-12-31 | $2.47 Billion | +7.09% |
| 2019-12-31 | $2.31 Billion | -5.79% |
| 2018-12-31 | $2.45 Billion | -5.36% |
| 2017-12-31 | $2.59 Billion | -6.38% |
| 2016-12-31 | $2.77 Billion | -1.18% |
| 2015-12-31 | $2.80 Billion | +120.84% |
| 2014-12-31 | $1.27 Billion | -8.90% |
| 2013-12-31 | $1.39 Billion | +380.11% |
| 2012-12-31 | $289.83 Million | +26.29% |
| 2011-12-31 | $229.49 Million | +194.80% |
| 2010-12-31 | $77.85 Million | -10.96% |
| 2009-12-31 | $87.43 Million | +301.72% |
| 2008-12-31 | $21.76 Million | -45.00% |
| 2007-12-31 | $39.57 Million | +352.10% |
| 2006-12-31 | $8.75 Million | -2.76% |
| 2005-12-31 | $9.00 Million | -10.63% |
| 2004-12-31 | $10.07 Million | -11.21% |
| 2003-12-31 | $11.34 Million | -35.24% |
| 2002-12-31 | $17.52 Million | -36.60% |
| 2001-12-31 | $27.62 Million | -26.09% |
| 2000-12-31 | $37.38 Million | +732.29% |
| 1999-12-31 | $4.49 Million | -41.68% |
| 1998-12-31 | $7.70 Million | +175.00% |
| 1997-12-31 | $2.80 Million | -28.21% |
| 1996-12-31 | $3.90 Million | -40.00% |
| 1995-12-31 | $6.50 Million | -- |
About Opko Health Inc
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigen… Read more